Discriminant Capacity and Thresholds of Salivary Cortisol in Chemiluminescence in the Diagnosis of Hypercorticisms

Inclusion Criteria: * The patient is under consultation in the department of metabolic and endocrine disorders at the CHU Nimes for diagnosis or follow-up of hypercortisol assessment * The patient must be a member or beneficiary of a health insurance plan Exclusion Criteria: * The patient is pregnant, parturient or breastfeeding * The patient has a cardiovascular or metabolic state against the indication of dexamethasone \- Patient with DFG \< 30 ml/min/1.73 m2 * The patient has suffered urinary incontinence rendering 24-hour urinary collection impossible or non-interpretable * The patient has a urinary catheter * The patient is taking corticoids (oral, inhaled, intra-venous or cutaneous) .Patient exposed to interfering treatments (Itraconazole, ritonavir, megestrol acetate, medroxyprogesterone acetate, TSH, estrogen-progestogen pill, hormonal coil) * The subject is in a period of exclusion determined by a previous study * The subject opposes their participation in the study * It is impossible to give the subject informed information * The patient is under safeguard of justice or state guardianship